An Incisive, In-depth Analysis on the Prefilled Syringes Drug Molecules Market
This study offers a comprehensive, 360 degree analysis on the Prefilled Syringes Drug Molecules market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Prefilled Syringes Drug Molecules market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Vaccines and Insulin are projected to closely compete in the global prefilled syringes drug molecules market during 2017-2027
The global prefilled syringes drug molecules market comprises various drug classes such as:
Vaccines: Vaccines an antigenic substance prepared from the causative agent of a disease or a synthetic substitute, used to provide immunity against one or several diseases
Insulin: Insulin is a peptide hormone produced by beta cells of the pancreatic islets
Adrenaline: Adrenaline, also known as Epinephrine is a hormone extracted from animals or produced synthetically for medicinal purposes
Opioids: The opioids covered in this report include prefilled syringes drug molecules used in the treatment of opioid overdose
The research report on the global prefilled syringes drug molecules market shows that among these drug classes, vaccines and insulin are expected to stay in a close competition during the forecast period. However, with a little difference, vaccines leads the market with a projected revenue of over US$ 23,200 Mn by the end of 2027. Insulin stays ahead in the race in terms of higher growth rate. The insulin segment is expected to register a CAGR of 6.6% during the forecast period.
Low reliance on health care professionals and surge in demand for self-administrated devices may boost the global prefilled syringes drug molecules market
Prefilled syringes drug delivery is preferred over conventional vials, as it facilitates various benefits such as less over-filling as well as safe and convenient use, thus increasing the demand for prefilled syringes drug molecules. Prefilled syringes drug delivery is convenient for patients who need parenteral administration of drugs on a daily or weekly basis and long term treatment. It makes them prefer more of self-administrated devices where patients don’t have to stay dependent on doctors for every dosage. Prefilled syringes provide inexpensive home setting medication and reduce time consumed at in-patient and out-patient care units. For patients requiring frequent dose administration on a weekly and daily basis, the use of prefilled syringes drug molecules reduces the average cost per injection, when compared to vials and ampoules. There is also a decrease in the reliance on health care professionals in many regions, and this is also likely to boost global market revenue growth.
Drug shortage in one of the most lucrative regions to hinder the growth of the prefilled syringes drug molecules market
North America is projected to be one of the most important regions for prefilled syringes drug molecules. However, North America is also experiencing drug shortage in rapidly increasing frequencies, which has been tracked by both American Society of Health-System Pharmacists (ASHP) and the US FDA. This has caused a difficult situation for health care facilities, patients and health care federal regulations. Companies are losing potential market revenue due to drug shortage. FDA has revised and updated the extended use date of drugs owing to the ongoing drugs shortage. Another major hindrance in the growth of the global prefilled syringes drug molecules market can be attributed to the premium pricing of auto-injectors and prefilled syringes. This is mainly due to the complex development process of prefilled syringes. The market is full of patented technologies that are used by many companies for the production of prefilled syringes, ultimately increasing the total cost of products.
As the healthcare and pharmaceutical industries are picking pace, the application of ready-to-use medical products has increased in various healthcare operations, which reflects in immense demand for prefilled syringes. Their applications in the healthcare industry as container closure systems for various types of biologic drug products such as vaccines and monoclonal antibodies, is triggering further innovation in prefilled syringes drug molecules.
The global demand for prefilled syringes drug molecules in a wide range of classes of drugs including vaccines, opioids, insulin, and adrenaline, is expected to boost growth of the market, especially in the personalised medication segment. Leading players in the prefilled syringes drug molecules market are expected to invest heavily in research & development for discovering innvotive delivery methods for ‘novel’ biologic and personalised drugs, to gain a competitive edge in this landscape.
Our new research report on the global prefilled syringes drug molecules market gives a brief overview of the global market. In this report, prefilled syringes drug molecules market includes revenue of prefilled syringes, auto-injectors, and prefilled pens. However, the report does not consider revenue of oral prefilled syringes drug molecules market. The report includes global prefilled syringes drug molecules market growth and the factors impacting this growth. The report describes the scenario of the global as well as the regional markets. The other segmentations of the market are on the basis of service type, application and end users. The segmentation bifurcates the market into simpler parts and thus helps in easier understanding and study of the market. The report includes an individual analysis of every segment, which gives minute details of the global prefilled syringes drug molecules market.
The key part of our report is the analysis and recommendations on the global prefilled syringes drug molecules market. The report takes an overview of the global prefilled syringes drug molecules market and also underlines factors influencing the growth of the global prefilled syringes drug molecules market. The analysts have also provided key strategic recommendations for both existing and new players in the market to emerge sustainably profitable. The report covers the competitive landscape that provides a dashboard view of companies that manufacture and provide services in the global prefilled syringes drug molecules market. The report contains company profiles of some of the key players and a strategic overview of mergers and acquisitions along with companies’ expansion plans across regions. Apart from including these factors, the team of expert analysts have also taken into consideration the various macro-economic indicators such as market outlook, gross domestic product and other pointers to arrive at the indicated market numbers. Top-down approach has been used to counter-validate the reached numbers in the global prefilled syringes drug molecules market, while bottom-up approach has been used to assess market numbers. Weighted average selling price is considered to estimate the market size mentioned in the scope of the study. The country price is captured with the local currency. The local currency figures are then converted to USD to offer forecasts in a consistent currency standard.
Our research methodology uses both primary and secondary research to collect the relevant data. We have analysed the market by considering the revenue through extensive primary research to understand the usage pattern, historic trends, key market developments, and most preferred products. Top opinion leaders have been considered for the primary research that include experienced professionals in various healthcare facilities and pharmaceutical companies. These estimates have further been validated with product manufacturers, distributors, and suppliers. Extensive secondary research has been carried out to understand the service rate, adoption rate, regulatory scenarios, average selling price, reimbursement scenario, by referring published scientific literature from various databases. We have also analysed various companies’ annual reports, investor presentations and press releases to fetch substantial information about the market size, trends, opportunities, drivers, restraints and to analyse and study key market players.
Prefilled Syringes Drug Molecules Market Reports - Table of Contents
10.14.Key Participants Market Presence (Intensity Map)
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
19. Assumptions and Acronyms Used
20. Research Methodology